Skip to main content
SpringerLink
Log in

Dopaminergic supersensitivity: Influence of dopamine agonists, cholinergics, anticholinergics, and drugs used for the treatment of tardive dyskinesia

  • Original Investigations
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Single and repeated administration of neuroleptics induce supersensitivity to dopamine agonists like apomorphine and methylphenidate. The degree of this supersensitivity depends on the period of the preceding administration of the neuroleptic.

In the development phase additional administration of apomorphine can reverse the hyperdopaminergic behaviour, whereas addition of cholinergic/anticholinergic treatment does not modify the enhanced receptor response. In the supersensitivity phase additional treatment with deanol does not modify the supersensitivity. Phenobarbital, diazepam, and muscimol increase and cis (Z)-flupenthixol decreases the supersensitivity.

It is concluded that supersensitivity induced by neuroleptics is time-dependent and that it can be prevented by additional treatment with DA-agonists but not by cholinergic/anticholinergic treatment. In the supersensitivity phase, the syndrome is suppressed by dopamine antagonists but enhanced by GABA-agonists, benzodiazepine and phenobarbital.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Arnt, J., Christensen, A. V., Scheel-Krüger, J.: Benzodiazepines potentiate GABA-dopamine dependent stereotyped gnawing in mice. J. Pharm. Pharmacol. 31, 56–58 (1979)

    Google Scholar 

  • Burt, D. R., Creese, I., Snyder, S. H.: Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain. Science 196, 326–328 (1977)

    Google Scholar 

  • Casey, D. E., Denney, D.: Pharmacological characterization of tardive dyskinesia. Psychopharmacology 54, 1–8 (1977)

    Google Scholar 

  • Christensen, A. V.: Acute and delayed effect of a single dose of a neuroleptic drug. Acta Physiol. Scand. 113 [Suppl. 396], 78 (1973)

    Google Scholar 

  • Christensen, A. V., Møller Nielsen, I.: Influence of flupenthixol and flupenthixol-decanoate on methylphenidate and apomorphine induced compulsive gnawing in mice. Psychopharmacologia 34, 119–126 (1974)

    Google Scholar 

  • Christensen, A. V., Fjalland, B., Møller Nielsen, I.: On the supersensitivity of dopamine receptors, induced by neuroleptics. Psychopharmacology 48, 1–6 (1976)

    Google Scholar 

  • Christensen, A. V., Møller Nielsen, I.: On the supersensitivity of DA-receptors after single and repeated administration of neuroleptics. In: Tardive dyskinesia research and treatment, R. C. Smith, W. E. Fann, S. M. Davis, and E. F. Domino, eds. New York: Spectrum 1979

    Google Scholar 

  • Costa, E., Gnegy, M. E., Uzunov, P.: Regulation of dopamine receptor sensitivity by an endogenous protein activator or adenylate cyclase. Naunyn-Schmiedebergs Arch. Pharmacol. 297, S47-S48 (1977)

    Google Scholar 

  • Costentin, J., Protais, P., Schwartz, J. C.: Rapid and dissociated changes in sensitivities of different dopamine receptors in mouse brain. Nature 257, 405–407 (1975)

    Google Scholar 

  • Creese, I., Burt, D. R., Snyder, S. H.: Dopamine receptor binding enhancement accompanies lesion-induced behavioral super-sensitivity. Science 197, 596–598 (1977)

    Google Scholar 

  • Ezrin-Waters, C., Seeman, P.: l-Dopa reversal of hyperdopaminergic behaviour. Life Sci. 22, 1027–1032 (1978)

    Google Scholar 

  • Fjalland, B., Møller Nielsen, I.: Enhancement of methylphenidate-induced stereotypies by repeated administration of neuroleptics. Psychopharmacologia 34, 105–109 (1974)

    Google Scholar 

  • Friedhoff, A. J., Bonnet, K., Rosengarten, H.: Reversal of two manifestations of dopamine supersensitivity by administration of l-dopa. Res. Commun. Chem. Pathol. Pharmacol. 16, 411–423 (1977)

    Google Scholar 

  • Gerlach, J., Reisby, N., Randrup, A.: Dopaminergic hypersensitivity and cholinergic hypofunction in the pathophysiology of tardive dyskinesia. Psychopharmacologia 34, 21–35 (1974)

    Google Scholar 

  • Gerlach, J., Thorsen, K.: The movement pattern of oral tardive dyskinesia in relation to anticholinergic and antidopaminergic treatment. Int. Pharmacopsychiatry 11, 1–7 (1976)

    Google Scholar 

  • Gerlach, J.: Relationship between tardive dyskinesia l-dopa-induced hyperkinesia and parkinsonism. Psychopharmacology 51, 259–263 (1977)

    Google Scholar 

  • Gerlach, J.: Tardive dyskinesia. Dan. Med. Bull. (in press, 1979)

  • Gianutsos, G., Hynes, M. D., Lal, H.: Enhancement of apomorphine-induced inhibition of striatal dopamine-turnover following chronic haloperidol. Biochem. Pharmacol. 24, 581–582 (1975)

    Google Scholar 

  • Gnegy, H., Uzunov, P., Costa, E.: Participation of an endogenous Ca++-binding protein activator in the development of drug-induced supersensitivity of striatal dopamine receptors. J. Pharmacol. Exp. Ther. 202, 558–564 (1977)

    Google Scholar 

  • Goldenthal, S.: Biofeedback and trait anxiety as factors in the operant control of GSR. Diss. Abst. Int. 36, 5852B (1976)

    Google Scholar 

  • Hyttel, J.: Long-term effects of teflutixol on the synthesis and endogenous levels of mouse brain catecholamines. J. Neurochem. 25, 681–686 (1975)

    Google Scholar 

  • Hyttel, J.: Levels of HVA and DOPAC in mouse corpus striatum in the supersensitivity phase after neuroleptic treatment. J. Neurochem. 28, 227–228 (1977)

    Google Scholar 

  • Hyttel, J.: Dopamine receptor binding and adenylate cyclase activity in mouse striatal tissue in the supersensitivity phase after neuroleptic treatment. Psychopharmacology (in press, 1978)

  • Iwatsubo, K., Clouet, D. H.: Dopamine sensitive adenylate cyclase of the caudate nucleus of rats treated with morphine or haloperidol. Biochem. Pharmacol. 24, 1499–1503 (1975)

    Google Scholar 

  • Kilbey, M. M., Ellinwood E. H., Jr.: Reverse tolerance to stimulant-induced abnormal behaviour. Life Sci. 20, 1063–1076 (1977)

    Google Scholar 

  • Klawans, H. L., Rubovitz, R.: An experimental model of tardive dyskinesia. J. Neural. Trans. 33, 235–246 (1972)

    Google Scholar 

  • Klawans, H. L.: Pharmacology of extrapyramidal movement disorders. Basel: Karger 1973

    Google Scholar 

  • Klawans, H. L., Crosset, P., Dana, N.: Effect of chronic amphetamine exposure on stereotyped behaviour. Implications for pathogenesis of l-dopa induced dyskinesia. Adv. Neurol. 9, 105–112 (1975)

    Google Scholar 

  • Klawans, H. L., Margolin, D. L.: Amphetamine-induced dopaminergic hypersensitivity in guinea-pigs. Arch. Gen. Psychiatry 32, 725–732 (1975)

    Google Scholar 

  • Kobayashi, R. M.: Drug therapy of tardive dyskinesia. N. Engl. J. Med. 296, 257–260 (1977)

    Google Scholar 

  • Martres, M. P., Costentin, J., Baudry, M., Marcais, H., Protais, P., Schwartz, J. C.: Long-term changes in the sensitivity of pre- and postsynaptic dopamine receptors in mouse striatum evidenced by behavioural and biochemical studies. Brain Res. 136, 319–337 (1978)

    Google Scholar 

  • Moore, K. E., Thornburg, J. E.: Drug-induced dopaminergic supersensitivity. Adv. Neurol. 9, 93–104 (1975)

    Google Scholar 

  • Muller, P., Seeman, P.: Brain neurotransmitter receptors after long term haloperidol: dopamine, acetylcholine, serotonin, α-noradrenergic and naloxone receptors. Life Sci. 21, 1751–1758 (1977)

    Google Scholar 

  • Møller Nielsen I., Christensen, A. V.: Long term effects of neuroleptic drugs. J. Pharmacol. (Paris) 6, 277–282 (1975)

    Google Scholar 

  • Møller Nielsen, I., Christensen, A. V., Hyttel, J.: Adaptational phenomena in neuroleptic treatment. Adv. Biochem. Psychopharmacol. 19, 267–274 (1978)

    Google Scholar 

  • Pedersen, V.: Potentiation of apomorphine effect (compulsive gnawing behaviour) in mice. Acta Pharmacol. (Kbh.) 25 (Suppl. 4], 63 (1967)

    Google Scholar 

  • Pedersen, V., Christensen, A. V.: Antagonism of methylphenidate-induced stereotyped gnawing in mice. Acta Pharmacol. (Kbh.) 31, 488–496 (1972)

    Google Scholar 

  • Protais, P., Costentin, J., Schwartz, J. C.: Climbing behaviour induced by apomorphine in mice: A simple test for the study of dopamine receptors in striatum. Psychopharmacology 50, 1–6 (1976)

    Google Scholar 

  • Sayers, A. C., Bürki, H. R., Ruch, W., Asper, H.: Neuroleptic-induced hypersensitivity of striatal dopamine receptors in the rat as a model of tardive dyskinesia. Effects of clozapine, haloperidol, loxapine and chlorpromazine. Psychopharmacologia 41, 97–104 (1975)

    Google Scholar 

  • Scheel-Krüger, J., Arnt, J., Braestrup, C., Christensen, A. V., Magelund, G.: Development for new animal models for GABA-ergic actions using muscimol as a tool. In: GABA-neurotransmitters. Alfred Benzon Symposium XII. H. Kofod, P. Krogsgaard-Larsen, and J. Scheel-Krüger, eds. pp. 447–464. Munksgaard 1979

  • Siegel, S.: The binomial test, nonparametric statistics for the behavioral sciences. New York: McGraw-Hill 1956

    Google Scholar 

  • Smith, R. C., Narasimhachari, N., Davis, J. M.: Increased effect of apomorphine on homovanillic acid in rats terminated from chronic haloperidol. J. Neural. Trans. 42, 159–162 (1978)

    Google Scholar 

  • Tarsy, D., Baldessarini, R. J.: Behavioural supersensitivity to apomorphine following chronic treatment with drugs which interfere with the synaptic function of catecholamines. Neuropharmacology 13, 927–940 (1974)

    Google Scholar 

  • Ther, L., Schramm, H.: Apomorphine-Synergismus (Zwangsnagen bei Mäusen) als Test zur Differenzierung psychotroper Substanzen. Arch. Int. Pharmacodyn. Ther. 138, 302–310 (1962)

    Google Scholar 

  • Van der Waerden, B. L., Nievergelt, E.: Tables for comparing two samples by X-test and sign test, pp. 22–25 Berlin: Springer 1956

    Google Scholar 

  • Von Voigtlander, P. F., Lorenz, E. G., Trienzenberg, H. J.: Increased sensitivity to dopaminergic agents after chronic neuroleptic treatment. J. Pharmacol. Exp. Ther. 193, 88–94 (1975)

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacology and Toxicology, H. Lundbeck & Co. A/S, Ottiliavej 7-9, DK-2500, Copenhagen-Valby, Denmark

    A. V. Christensen & I. Møller Nielsen

Authors
  1. A. V. Christensen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. I. Møller Nielsen
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Christensen, A.V., Nielsen, I.M. Dopaminergic supersensitivity: Influence of dopamine agonists, cholinergics, anticholinergics, and drugs used for the treatment of tardive dyskinesia. Psychopharmacology 62, 111–116 (1979). https://doi.org/10.1007/BF00427122

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00427122

Key words

Search

Navigation